Ceeable, Inc.

Web enabled technology to reduce blindness

Shareable draft

Check out Ceeable, Inc. on @MedStartr Today Web enabled technology to reduce blindness. #AlternativeTherapies #MedMo #MedStartrVentures

https://www.medstartr.ai/s/aNJxM6AY8pc

Get Involved in Ceeable, Inc.

How We Help

Company Info

Clinical & IP

🔬

Clinical Validation

<p>The Ceeable technology is a clinically validated platform that has been tested on over 3000 patients. A recent study published in the British Journal of Ophthalmology titled “Early detection of glaucoma by means of a novel 3D computer-automated visual field test” demonstrated that the CVFA technology could detect the early onset of Glaucoma in several individuals before it was apparent using the Humphrey Visual Field Analyzer (Nazemi et al., 2007). The early onset detection of macular degeneration has also been reported in one of the studies (Nazemi et al., 2004). Further, another unrelated study recently demonstrated that CVFA could detect large-scale visual field defects in patients with ethambutol-induced optic neuropathy well before they were detectable by standard-automated perimetry (Kim et al., 2008). A study published in 2016 demonstrated the superiority of the Ceeable technology over microperimetry in determining small retinal defects (Milyutkina, et.al. 2016).  Although the research on early detection and classification of visual field defects with CVFA is still in process, the initial results are very promising.</p>

🛡️

IP Protection

—

View Patent →

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Ceeable, Inc.?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.